Safety aspects of local endobronchial allergen challenge in asthmatic patients. 1996

N Krug, and L M Teran, and A E Redington, and C Gratziou, and S Montefort, and R Polosa, and H Brewster, and P H Howarth, and S T Holgate, and A J Frew, and M P Carroll
Immunopharmacology Group, University Medicine, Southampton General Hospital, United Kingdom.

Local endobronchial allergen challenge is being increasingly used to investigate the role of allergic inflammation in asthma. However, little information is available about the safety of this procedure and the changes induced in airway physiology. BAL and biopsy were performed at 10 min and at 4 to 6 h, or 24 h after segmental allergen challenge in 49 patients with atopic asthma. Two hours after challenge, FEV1 was reduced from 97.6 +/- 13.9 (mean +/- SD) to 83.4 +/- 21.7% predicted. FEV1 remained reduced at 4 to 6 h (87.7 +/- 20.4%), but it had nearly returned to baseline by 24 h (93.2 +/- 14.0%). When endobronchial challenge was combined with BAL and biopsy, the initial fall in FEV1 was slightly greater (from 101.8 +/- 14.2 to 78.5 +/- 13.6%). Bronchial responsiveness to methacholine was measured in 10 subjects, and it showed a twofold increase 24 h after local challenge and lavage. Significant changes in FEV1 and methacholine PC20 were still detectable 72 h after challenge. Widespread wheezing occurred in 29% of the subjects, but none of the them had to be admitted to hospital. We conclude that local endobronchial allergen challenge, although producing measurable changes in airway physiology, is in general well tolerated and is an acceptable method to investigate airway pathophysiologic processes in patients with mild to moderate asthma.

UI MeSH Term Description Entries
D008297 Male Males
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D001985 Bronchial Provocation Tests Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma. Allergen Bronchial Provocation Tests,Allergen Challenge, Endobronchial,Antigen Bronchial Provocation Tests,Bronchial Allergen Challenge,Bronchial Challenge Tests,Inhalation Provocation Tests,Provocation Tests, Bronchial,Endobronchial Challenge Tests,Allergen Challenge, Bronchial,Allergen Challenges, Bronchial,Allergen Challenges, Endobronchial,Bronchial Allergen Challenges,Bronchial Challenge Test,Bronchial Provocation Test,Challenge Test, Bronchial,Challenge Test, Endobronchial,Challenge Tests, Bronchial,Challenge Tests, Endobronchial,Challenge, Bronchial Allergen,Challenge, Endobronchial Allergen,Challenges, Bronchial Allergen,Challenges, Endobronchial Allergen,Endobronchial Allergen Challenge,Endobronchial Allergen Challenges,Endobronchial Challenge Test,Inhalation Provocation Test,Provocation Test, Bronchial,Provocation Test, Inhalation,Provocation Tests, Inhalation,Test, Bronchial Challenge,Test, Bronchial Provocation,Test, Endobronchial Challenge,Test, Inhalation Provocation,Tests, Bronchial Challenge,Tests, Bronchial Provocation,Tests, Endobronchial Challenge,Tests, Inhalation Provocation
D001999 Bronchoscopy Endoscopic examination, therapy or surgery of the bronchi. Bronchoscopic Surgical Procedures,Surgical Procedures, Bronchoscopic,Bronchoscopic Surgery,Surgery, Bronchoscopic,Bronchoscopic Surgeries,Bronchoscopic Surgical Procedure,Bronchoscopies,Surgeries, Bronchoscopic,Surgical Procedure, Bronchoscopic
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies

Related Publications

N Krug, and L M Teran, and A E Redington, and C Gratziou, and S Montefort, and R Polosa, and H Brewster, and P H Howarth, and S T Holgate, and A J Frew, and M P Carroll
July 1996, The Journal of allergy and clinical immunology,
N Krug, and L M Teran, and A E Redington, and C Gratziou, and S Montefort, and R Polosa, and H Brewster, and P H Howarth, and S T Holgate, and A J Frew, and M P Carroll
March 1998, The European respiratory journal. Supplement,
N Krug, and L M Teran, and A E Redington, and C Gratziou, and S Montefort, and R Polosa, and H Brewster, and P H Howarth, and S T Holgate, and A J Frew, and M P Carroll
April 1992, The American review of respiratory disease,
N Krug, and L M Teran, and A E Redington, and C Gratziou, and S Montefort, and R Polosa, and H Brewster, and P H Howarth, and S T Holgate, and A J Frew, and M P Carroll
January 1992, Allergologia et immunopathologia,
N Krug, and L M Teran, and A E Redington, and C Gratziou, and S Montefort, and R Polosa, and H Brewster, and P H Howarth, and S T Holgate, and A J Frew, and M P Carroll
November 1997, American journal of respiratory and critical care medicine,
N Krug, and L M Teran, and A E Redington, and C Gratziou, and S Montefort, and R Polosa, and H Brewster, and P H Howarth, and S T Holgate, and A J Frew, and M P Carroll
January 1996, Allergologia et immunopathologia,
N Krug, and L M Teran, and A E Redington, and C Gratziou, and S Montefort, and R Polosa, and H Brewster, and P H Howarth, and S T Holgate, and A J Frew, and M P Carroll
January 1996, Allergologia et immunopathologia,
N Krug, and L M Teran, and A E Redington, and C Gratziou, and S Montefort, and R Polosa, and H Brewster, and P H Howarth, and S T Holgate, and A J Frew, and M P Carroll
March 1986, Annals of allergy,
N Krug, and L M Teran, and A E Redington, and C Gratziou, and S Montefort, and R Polosa, and H Brewster, and P H Howarth, and S T Holgate, and A J Frew, and M P Carroll
January 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
N Krug, and L M Teran, and A E Redington, and C Gratziou, and S Montefort, and R Polosa, and H Brewster, and P H Howarth, and S T Holgate, and A J Frew, and M P Carroll
February 1987, The American review of respiratory disease,
Copied contents to your clipboard!